-
Uncategorized2 weeks ago
FDA accepts BridgeBio’s application for potential first limb-girdle muscular dystrophy drug
FDA accepts BridgeBio’s application for potential first limb-girdle muscular dystrophy drug
-
Uncategorized2 weeks agoCardio drugmaker Kardigan plans to go public
Founded by former MyoKardia executives, the startup has in mid- to late-stage testing three medicines licensed from the likes of Sanofi, Ionis and Bristol Myers Squibb....
-
Uncategorized2 weeks ago
Automation and AI Will Drive Next-Gen CAR T Manufacturing
The remarkable clinical success of CAR T therapies in blood cancers has validated the promise of engineered cell therapies. But according to Adam Janvier, PhD, head...
-
Uncategorized2 weeks ago
Apogee investors riled by $1.3B royalty deal, as eczema drug matches Lilly’s Ebglyss
Apogee’s pipeline in a product drug zumilokibart achieved significant disease clearance in a mid-stage atopic dermatitis trial, but investors were miffed by a royalty financing deal...
-
Uncategorized2 weeks agoOpinion: MIT president: Why so many optimistic scientists are losing heart
Most successful scientists are optimists. They have to be, since the vast majority of experiments fail. In graduate school, I remember sitting in the lab at...
-
Uncategorized2 weeks agoGenetic pattern key to colorectal cancer, research shows
A genetic pattern could explain how colorectal cancer develops, new research suggests. Findings from ChristianaCare’s Helen F Graham Cancer Center & Research Institute identified a developmental genetic pattern that helps explain...
-
Uncategorized2 weeks agoSTAT+: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more
Good morning, everyone, and how are you today? The middle of the week has finally arrived, and you should congratulate yourselves for making it this far...
-
Uncategorized2 weeks ago
Lilly just bought renowned regulator Peter Marks a pipeline to play with
FDA veteran Peter Marks will now shape the future of Eli Lilly’s vaccines work after the buys of Curevo, LimmaTech Biologics and Vaccine Company for up...
-
Uncategorized2 weeks agoSTAT+: Where patients and hospitals disagree about AI
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in...
-
Uncategorized2 weeks agoBiohub Releases Protein Biology World Model to Address Disease
Biohub Releases Protein Biology World Model to Address Disease
Beyond sunshine: Iberia’s biotech moment has arrived with developing capital networks
Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins
